Elan Settles

Elan Corp. (NYSE: ELN), an Ireland-based pharmaceutical company, has announced the preliminary settlement of the securities class action pending against the company in the S.D.N.Y. The case, originally filed in 2002, alleges that Elan engaged in accounting violations. The settlement is for $75 million, with $35 million to be paid by the company and $40 million by its insurance carrier.

Addition: An interesting sidenote – Elan is the parent company of Dura Pharmaceuticals, the defendant in the loss causation case currently before the U.S. Supreme Court.

Leave a comment

Filed under Settlement

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s